These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22867774)

  • 21. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
    Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
    [No Abstract]   [Full Text] [Related]  

  • 22. Racial variation in the cost-effectiveness of chemotherapy for prostate cancer.
    Grabner M; Onukwugha E; Jain R; Mullins CD
    Am J Manag Care; 2011 May; 17(5 Spec No):e151-9. PubMed ID: 21711065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linking Costs and Survival in the Treatment of Older Adults With Chronic Myeloid Leukemia: An Analysis of SEER-Medicare Data From 1995 to 2007.
    Lin PJ; Winn AN; Parsons SK; Neumann PJ; Weiss ES; Cohen JT
    Med Care; 2016 Apr; 54(4):380-5. PubMed ID: 26759984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare.
    Ramsey SD; Howlader N; Etzioni RD; Donato B
    J Clin Oncol; 2004 Dec; 22(24):4971-8. PubMed ID: 15611512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating medical costs from incomplete follow-up data.
    Lin DY; Feuer EJ; Etzioni R; Wax Y
    Biometrics; 1997 Jun; 53(2):419-34. PubMed ID: 9192444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999-2006.
    Sathiakumar N; Delzell E; Morrisey MA; Falkson C; Yong M; Chia V; Blackburn J; Arora T; Brill I; Kilgore ML
    Breast Cancer Res Treat; 2012 Jan; 131(1):231-8. PubMed ID: 21842243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy.
    Baxter NN; Durham SB; Phillips KA; Habermann EB; Virning BA
    J Am Geriatr Soc; 2009 Mar; 57(3):403-11. PubMed ID: 19278395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of Medicare Costs for Elderly Patients With Oral Cavity and Pharyngeal Cancers.
    Hollenbeak CS; Kulaylat AN; Mackley H; Koch W; Schaefer EW; Goldenberg D
    JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):628-35. PubMed ID: 26042925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.
    Doyle JJ; Neugut AI; Jacobson JS; Grann VR; Hershman DL
    J Clin Oncol; 2005 Dec; 23(34):8597-605. PubMed ID: 16314622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment for breast cancer in patients with Alzheimer's disease.
    Gorin SS; Heck JE; Albert S; Hershman D
    J Am Geriatr Soc; 2005 Nov; 53(11):1897-904. PubMed ID: 16274370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression analysis of grouped survival data: informative censoring and double sampling.
    Baker SG; Wax Y; Patterson BH
    Biometrics; 1993 Jun; 49(2):379-89. PubMed ID: 8369374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.
    Hershman DL; Buono D; McBride RB; Tsai WY; Joseph KA; Grann VR; Jacobson JS
    J Natl Cancer Inst; 2008 Feb; 100(3):199-206. PubMed ID: 18230795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managed care enrollment and chronically disabled women with breast cancer.
    Habermann EB; Virnig BA; Durham SB; Baxter NN
    Am J Manag Care; 2008 Aug; 14(8):514-20. PubMed ID: 18690767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating mean total costs in the presence of censoring: a comparative assessment of methods.
    Young TA
    Pharmacoeconomics; 2005; 23(12):1229-42. PubMed ID: 16336017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression modeling of restricted mean survival time for left-truncated right-censored data.
    Rong R; Ning J; Zhu H
    Stat Med; 2022 Jul; 41(16):3003-3021. PubMed ID: 35708238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of Medicare costs in elderly beneficiaries with breast, colorectal, lung, or prostate cancer.
    Penberthy L; Retchin SM; McDonald MK; McClish DK; Desch CE; Riley GF; Smith TJ; Hillner BE; Newschaffer CJ
    Health Care Manag Sci; 1999 Jul; 2(3):149-60. PubMed ID: 10934539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing least-squares and quantile regression approaches to analyzing median hospital charges.
    Olsen CS; Clark AE; Thomas AM; Cook LJ
    Acad Emerg Med; 2012 Jul; 19(7):866-75. PubMed ID: 22805633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propensity score and doubly robust methods for estimating the effect of treatment on censored cost.
    Li J; Handorf E; Bekelman J; Mitra N
    Stat Med; 2016 May; 35(12):1985-99. PubMed ID: 26678242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Weighted quantile regression for analyzing health care cost data with missing covariates.
    Sherwood B; Wang L; Zhou XH
    Stat Med; 2013 Dec; 32(28):4967-79. PubMed ID: 23836597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of entropy balance and probability weighting methods to generalize observational cohorts to a population: a simulation and empirical example.
    Harvey RA; Hayden JD; Kamble PS; Bouchard JR; Huang JC
    Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):368-377. PubMed ID: 27859943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.